DMARDs, a Guide to Monitoring Requirements

Tests for patients on disease-modifying arthritis drugs.

Remind yourself of the monitoring requirements for disease-modifying antirheumatic drugs with the MIMS DMARDs table

This table summarises the ongoing tests advised for patients taking the DMARDs azathioprine, chloroquine, ciclosporin, hydroxychloroquine, leflunomide, methotrexate, penicillamine, sodium aurothiomalate (gold) or sulfasalazine.     

Tests include:

  • full blood counts
  • liver function tests
  • ophthalmological examination
  • renal function and urinalysis
  • blood pressure
  • serum lipids
  • chest x-ray
  • plasma drug levels

The recommended frequency of testing is also noted in the table.

Brand names link through to the full MIMS entries for more detailed prescribing information on each product.

Go to the MIMS DMARDs table


Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases